Memorial Sloan Kettering

Participants in the Terry Fox Run deserve to know how their hard earned contributions impact the field of cancer research. To this end, we are very pleased to report that the research conducted at Memorial Sloan Kettering Cancer Center by Dr. Renier Brentjens directly supported by contributions raised by the Terry Fox Run has recently yielded very promising clinical results in patients with B cell cancers. Specifically, the work pioneered at MSKCC and adapted at other cancer centers using gene therapy techniques to stimulate the immune system to kill tumor cells has resulted in profoundly promising results in patients with advanced B cell cancers including non-Hodgkins lymphomas, chronic lymphocytic leukemias, and acute lymphoblastic leukemias.